hydroxychloroquine has been researched along with warfarin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Huguier, M; Uhl, JF | 1 |
| Ahmed, W; Maddison, PJ; Seale, JR; Thorpe, C; Whiteley, GS | 1 |
| Nasonov, EL | 1 |
| Harten, P | 1 |
| Capelo, J; Carragoso, A; Faria, B; Gaspar, O; Silva, JR | 1 |
| Baig, MS; Humail, SM; Riaz, A; Suhail, S | 1 |
| Khamashta, MA; Scoble, T; Wijetilleka, S | 1 |
| Chang, YS; Chen, WS; Chou, CT; Hong, JY; Hsiao, KH; Lai, CC | 1 |
| Foster, CS; Kruh, JN; Yang, P | 1 |
| Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
| Bell, A; Contractor, T; Khasnis, A; Martinez, MW; Silverberg, BJ | 1 |
| Belizna, C; Camarzana, A; Jaquinandi, V; Le Tourneau, T; Mahe, G; Mezdad, TH; Omarjee, L; Rouleau, F | 1 |
| Chen, L; Chi, H; Hou, J; Meng, J; Su, Y; Wang, Z; Yang, C | 1 |
| Cheng, CY; Chu, KCW; Hsu, CW; Huang, WC; Yang, CH | 1 |
| Baik, SH; Baye, F; Fung, KW; Huser, V; McDonald, CJ; Zheng, Z | 1 |
5 review(s) available for hydroxychloroquine and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; Heparin; Humans; Hydroxychloroquine; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Random Allocation; Thromboembolism; Thrombophlebitis | 1979 |
Management of refractory anti-phospholipid syndrome.
Topics: Antibodies, Monoclonal, Murine-Derived; Antiphospholipid Syndrome; Clinical Trials as Topic; Evidence-Based Medicine; Female; Fetal Death; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Pregnancy; Rituximab; Secondary Prevention; Thrombosis; Warfarin | 2011 |
Antiphospholipid antibody syndrome.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Humans; Hydroxychloroquine; Retinal Artery Occlusion; Retinal Vein Occlusion; Warfarin | 2012 |
Probable catastrophic antiphospholipid syndrome secondary to chronic myelomonocytic leukaemia in an adult patient and a mini review.
Topics: Antiphospholipid Syndrome; Bone Marrow; Computed Tomography Angiography; Humans; Hydroxychloroquine; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Prednisone; Thrombosis; Warfarin | 2020 |
12 other study(ies) available for hydroxychloroquine and warfarin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
'Catastrophic' antiphospholipid syndrome.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Critical Illness; Female; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Prednisolone; Respiratory Distress Syndrome; Treatment Outcome; Warfarin; White People | 2000 |
[Current approaches to prevention and treatment of antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Contraceptives, Oral; Enzyme Inhibitors; Female; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Male; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Risk Factors; Smoking; Time Factors; Warfarin | 2003 |
[Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Azathioprine; Coumarins; Cyclophosphamide; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Pregnancy; Time Factors | 2003 |
A patient with sarcoidosis and antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Middle Aged; Prednisolone; Sarcoidosis, Pulmonary; Treatment Outcome; Warfarin | 2008 |
Primary antiphospholipid antibody syndrome and autoimmune haemolytic anaemia--a rare combination.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Azathioprine; Comorbidity; Female; Glucocorticoids; Humans; Hydroxychloroquine; Prednisolone; Warfarin | 2009 |
Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome.
Topics: Adolescent; Antiphospholipid Syndrome; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infarction; Intestines; Kidney; Lupus Erythematosus, Systemic; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis; Warfarin | 2012 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Antiphospholipid antibody-associated non-infective mitral valve endocarditis successfully treated with medical therapy.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Drug Therapy, Combination; Endocarditis, Non-Infective; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunomodulation; Mitral Valve; Mitral Valve Insufficiency; Prednisone; Warfarin; Young Adult | 2013 |
Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Drug Therapy, Combination; Endocarditis; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Treatment Outcome; Vitamin K; Warfarin; Young Adult | 2018 |
Man With Right Flank Pain.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Flank Pain; Humans; Hydroxychloroquine; Infarction; Kidney; Male; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Warfarin | 2020 |
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19 Drug Treatment; Factor Xa Inhibitors; Famotidine; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Medicare; Retrospective Studies; United States; Warfarin | 2022 |